Hans Wildiers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

Aditya Bardia, Xichun Hu, Rebecca Dent et al. · New England Journal of Medicine · 2024 · 393 citations

Medicine, Oncology, Pharmacotherapy +17

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Heikki Joensuu, Judith Fraser, Hans Wildiers et al. · JAMA Oncology · 2018 · 149 citations · Full text

Medicine, Oncology, Pharmacology +17

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

Hans Wildiers, Christel Fontaine, Peter Vuylsteke et al. · Breast Cancer Research and Treatment · 2010 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors

Tim Van den Wyngaert, M. Delforge, Chantal Doyen et al. · Supportive Care in Cancer · 2013 · 26 citations

Medicine, Oncology, Pharmacotherapy +17